Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 336 publications

Cyclic IMS-MS Reveals Protonation-Site Preservation in Isobaric Fragments of Quizartinib Protomers via Charge-Remote Fragmentation.

Cyclic IMS-MS Reveals Protonation-Site Preservation in Isobaric Fragments of Quizartinib Protomers via Charge-Remote Fragmentation.

Journal: Journal of the American Society for Mass Spectrometry
Published: December 07, 2025

Erratum: Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Erratum: Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2025

Treatment of high-risk acute myeloid leukemia

Treatment of high-risk acute myeloid leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: November 05, 2025

Acute myeloid leukemia therapy in the era of comprehensive genomic profiling

Acute myeloid leukemia therapy in the era of comprehensive genomic profiling

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: November 05, 2025

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors.

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors.

Journal: Journal of visualized experiments : JoVE
Published: November 03, 2025

Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2025

Quizartinib for Newly Diagnosed FLT3-ITD-Negative Acute Myeloid Leukemia: The Randomized, Double-Blind, Placebo-Controlled, Phase 2 QUIWI Study.

Quizartinib for Newly Diagnosed FLT3-ITD-Negative Acute Myeloid Leukemia: The Randomized, Double-Blind, Placebo-Controlled, Phase 2 QUIWI Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2025

Recent insights and clinical issues in acute myeloid leukemia in older adults

Recent insights and clinical issues in acute myeloid leukemia in older adults

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025

Preliminary assessment of drug repurposing against virus-associated primary effusion lymphoma.

Preliminary assessment of drug repurposing against virus-associated primary effusion lymphoma.

Journal: Journal of microbiology & biology education
Published: September 25, 2025

FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML.

FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML.

Journal: Cancers
Published: September 25, 2025

3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia.

3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia.

Journal: European journal of medicinal chemistry
Published: September 16, 2025

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors.

Acute myeloid leukemia drug resistance: targetable nodes and the clinical trajectory of small-molecule inhibitors.

Journal: Frontiers in pharmacology
Published: August 31, 2025
Showing 1-12 of 336

Last Updated: 01/07/2026